Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul-Aug;8(4):241-248.
doi: 10.4103/eus.eus_63_18.

Adverse events with lumen-apposing metal stents in endoscopic gallbladder drainage: A systematic review and meta-analysis

Babu P Mohan  1 , Ravishankar Asokkumar  2 , Mohammed Shakhatreh  3 , Rajat Garg  4 , Suresh Ponnada  5 , Udayakumar Navaneethan  6 , Douglas G Adler  7
Affiliations

Adverse events with lumen-apposing metal stents in endoscopic gallbladder drainage: A systematic review and meta-analysis

Babu P Mohan et al. Endosc Ultrasound. 2019 Jul-Aug.

Abstract

Background: Lumen-apposing metal stents (LAMS) are rapidly being used in endoscopic interventional drainage procedures and have started to replace the self-expanding metal stents (SEMSs). Its use in gallbladder drainage (GBD) is limited by lack of good-quality studies, and data are scarce on its safety.

Methods: We conducted a comprehensive search of multiple electronic databases and conference proceedings including PubMed, Embase, and Web of Science databases (from inception through July 2018) to identify studies that reported on the use of LAMS in GBD. The outcomes measured were the pooled rates of all adverse events (AEs), pooled rates of early AEs and pooled rates of delayed AEs.

Results: A total of 8 studies (393 patients) were included. The pooled rate of all AEs was 12.7% (95% CI 8.4-18.7, I2= 7.7) compared to 17.5% (95% CI 10.2-28.2, I2= 65.1) with other SEMS, P = 0.39. The rate of early AEs with LAMS in endoscopic ultrasound-GBD (EUS-GBD) was 6.5% (95% CI 4.2-10, I2= 1.2), and the rate of delayed AEs was 8.3% (95% CI 5.8-11.9, I2 = 4.8). The rate of recurrent cholecystitis and/or cholangitis was 4.6% (95% CI 2.6-9.5, I2= 0) and the pooled rate of death was 5% (95% CI 2.6-9.5, I2 = 36.4).

Conclusion: We report an overall AE rate of 13% with LAMS in EUS-GBD. Early AE risk appears to be 6.5% and delayed AE risk appears to be 8%. Our results are analyzed out of good-quality studies, with minimal to zero heterogeneity.

Keywords: Adverse events; gallbladder drainage; lumen-apposing metal stents; self-expanding metal stents.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Study flow and selection. LAMS: Lumen-apposing metal stent
Figure 2
Figure 2
Forest plot - overall adverse events
Figure 3
Figure 3
Forest plot - overall early adverse events
Figure 4
Figure 4
Forest plot - overall delayed adverse events
See this image and copyright information in PMC

References

    1. Itoi T, Binmoeller KF, Shah J, et al. Clinical evaluation of a novel lumen-apposing metal stent for endosonography-guided pancreatic pseudocyst and gallbladder drainage (with videos) Gastrointest Endosc. 2012;75:870–6. - PubMed
    1. Teoh AY, Ng EK, Chan SM, et al. Ex vivo comparison of the lumen-apposing properties of EUS-specific stents (with video) Gastrointest Endosc. 2016;84:62–8. - PubMed
    1. Yang D, Nieto JM, Siddiqui A, et al. Lumen-apposing covered self-expandable metal stents for short benign gastrointestinal strictures: A multicenter study. Endoscopy. 2017;49:327–33. - PubMed
    1. Siddiqui AA, Kowalski TE, Loren DE, et al. Fully covered self-expanding metal stents versus lumen-apposing fully covered self-expanding metal stent versus plastic stents for endoscopic drainage of pancreatic walled-off necrosis: Clinical outcomes and success. Gastrointest Endosc. 2017;85:758–65. - PubMed
    1. Dollhopf M, Larghi A, Will U, et al. EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device. Gastrointest Endosc. 2017;86:636–43. - PubMed